Pharmaceutical Analysis & Statistics in Oceania Countries, October 2014 (p6)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

You might be interested in: Therapeutics, Drug, Cancer, more »

151-200 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
Neuren Pharmaceuticals Limited (Symbol:NEU) SWOT Analysis, Strategy, Revenues and Profits

Neuren Pharmaceuticals Limited (Symbol:NEU) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : New Zealand, Australia
Plethico Pharmaceuticals Limited (PLETHICO) - Financial and Strategic SWOT Analysis Review

Plethico Pharmaceuticals Limited (PLETHICO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Plethico Pharmaceuticals Limited (Plethico) is a pharmaceutical and healthcare company. The company manufactures, markets and distributes pharmaceutical and allied healthcare products. Plethico ...

  • Industries : Pharmaceutical
  • Countries : Australia
Pharmanet Group Ltd (Symbol:PNO) SWOT Analysis, Strategy, Revenues and Profits

Pharmanet Group Ltd (Symbol:PNO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : United States, Australia, India
Suda Ltd (SUD) - Financial and Strategic SWOT Analysis Review

Suda Ltd (SUD) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Suda Ltd (Suda) is a drug delivery company. The company develops and markets oro-mucosal drug delivery technology for development of pharmaceuticals. Its products include ArTiMist, SUD-001, SUD-002, ...

  • Industries : Drug Delivery Technology
  • Countries : Australia
Viralytics Ltd. (Symbol:VLA) SWOT Analysis, Strategy, Revenues and Profits

Viralytics Ltd. (Symbol:VLA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia, United States
YM BioSciences Inc. (Symbol:YM) SWOT Analysis, Strategy, Revenues and Profits

YM BioSciences Inc. (Symbol:YM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Canada, Australia
Cryosite Limited (Symbol:CTE) SWOT Analysis, Strategy, Revenues and Profits

Cryosite Limited (Symbol:CTE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : Australia
DONGKOOK Pharmaceutical Co., Ltd. (Symbol:086450) SWOT Analysis, Strategy, Revenues and Profits

DONGKOOK Pharmaceutical Co., Ltd. (Symbol:086450) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : Australia, World
Somnomed Limited (Symbol:SOMDA) SWOT Analysis, Strategy, Revenues and Profits

Somnomed Limited (Symbol:SOMDA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia, United States, Spain, Portugal
Strides Arcolab Limited (STAR) - Financial and Strategic SWOT Analysis Review

Strides Arcolab Limited (STAR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Strides Arcolab Limited (Strides Arcolab) is a pharmaceutical company. The company specializes in manufacturing soft gelatin capsules. Strides Arcolab serves areas such as pharma generics, branded ...

  • Industries : Pathology
  • Countries : United States, World, Australia, South Africa
Sunshine Heart Company, Pty. Ltd. (Symbol:SHC) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Heart Company, Pty. Ltd. (Symbol:SHC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
Pacific Edge Limited (Symbol:PEB) SWOT Analysis, Strategy, Revenues and Profits

Pacific Edge Limited (Symbol:PEB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : New Zealand, United States
CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis Review

CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary CCM Duopharma Biotech Bhd. (CCM Duopharma) is an investment holding company. The company conducts manufacturing, distributing, importing, and exporting of pharmaceutical products and medicines. ...

  • Industries : Drug and Medication
  • Countries : Yemen, Asia, Papua New Guinea, Sri Lanka, Singapore, Bangladesh
Mylan Laboratories Limited - Strategic SWOT Analysis Review

Mylan Laboratories Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Mylan Laboratories Limited (Mylan Laboratories) is a pharmaceutical company. The company's product segments include manufacturing and supply of active pharmaceutical ingredients (APIs). The company ...

  • Industries : Drug and Medication
  • Countries : United States, India, World, Australia, South Africa, China
Mayne Pharma Group Limited (MYX) - Financial and Strategic SWOT Analysis Review

Mayne Pharma Group Limited (MYX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Mayne Pharma Group Limited (Mayne Pharma) is a pharmaceutical company. The company develops, manufactures, and commercializes branded and generic pharmaceutical products. Its products include Aspirin ...

  • Industries : Pharmaceutical
  • Countries : Australia
J. B. Chemicals & Pharmaceuticals Ltd. (JBCHEPHARM) - Financial and Strategic SWOT Analysis Review

J. B. Chemicals & Pharmaceuticals Ltd. (JBCHEPHARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL) is a pharmaceutical company. It focuses on contract manufacturing. JBCPL's products include Dicloran, Ificipro, Cefotaxime injection, Flodemex tablets, ...

  • Industries : Pharmaceutical
  • Countries : Australia, South Africa
Invion Limited (IVX) - Financial and Strategic SWOT Analysis Review

Invion Limited (IVX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Invion Limited (Invion) is a clinical-stage pharmaceutical company. It develops and markets products for the treatment of inflammatory diseases including chronic inflammatory airway disease and ...

  • Industries : Pathology
  • Countries : Australia
Prima BioMed Ltd. (PRR) - Financial and Strategic SWOT Analysis Review

Prima BioMed Ltd. (PRR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Prima BioMed Ltd. (Prima BioMed) is a biotechnology company. The company develops personalized immunocellular therapeutic products for cancer treatment. Its CVac therapy is an immunocellular therapeutic ...

  • Industries : Pathology
  • Countries : Australia
Taisho Pharmaceutical Co., Ltd. - Strategic SWOT Analysis Review

Taisho Pharmaceutical Co., Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Taisho Pharmaceutical Co., Ltd. (Taisho) is a pharmaceutical company. The company carries out the development, manufacture and marketing of various pharmaceutical products. Its products include ...

  • Industries : Pharmaceutical
  • Countries : Philippines, Japan, United States, Australia, Indonesia, Asia, Vietnam, Thailand, Taiwan, Malaysia, China
Bafna Pharmaceuticals Limited (BAFNAPHARM) - Financial and Strategic SWOT Analysis Review

Bafna Pharmaceuticals Limited (BAFNAPHARM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Bafna Pharmaceuticals Limited (Bafna Pharmaceuticals) is a pharmaceutical company. The company manufactures and markets a range of pharmaceutical products. Its operations include domestic marketing, ...

  • Industries : Pharmaceutical
  • Countries : Australia
Olainfarm (OLF1R) - Financial and Strategic SWOT Analysis Review

Olainfarm (OLF1R) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Olainfarm is a pharmaceutical company. The company manufactures oral dosage medicament forms, chemical ingredients and active pharmaceutical ingredients. It offers a wide range of prescription ...

  • Industries : Prescription Drug
  • Countries : Australia, Russian Federation, Latvia
Acuvax Ltd (Symbol:ACU) SWOT Analysis, Strategy, Revenues and Profits

Acuvax Ltd (Symbol:ACU) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
Giaconda Limited (Symbol:GIA) SWOT Analysis, Strategy, Revenues and Profits

Giaconda Limited (Symbol:GIA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : Australia
Patrys Limited (Symbol:PAB) SWOT Analysis, Strategy, Revenues and Profits

Patrys Limited (Symbol:PAB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
Virax Holdings Limited (Symbol:VHL) SWOT Analysis, Strategy, Revenues and Profits

Virax Holdings Limited (Symbol:VHL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
Vita Life Sciences Limited (Symbol:VSC) SWOT Analysis, Strategy, Revenues and Profits

Vita Life Sciences Limited (Symbol:VSC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Vitamin and Supplement
  • Countries : Philippines, Australia, Singapore, Indonesia
Life Therapeutics Limited (Symbol:LFE) SWOT Analysis, Strategy, Revenues and Profits

Life Therapeutics Limited (Symbol:LFE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Therapy
  • Countries : Australia
Mayne Pharma Limited (Symbol:MYP) SWOT Analysis, Strategy, Revenues and Profits

Mayne Pharma Limited (Symbol:MYP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Delivery Technology
  • Countries : Australia
Stirling Products Limited (Symbol:STI) SWOT Analysis, Strategy, Revenues and Profits

Stirling Products Limited (Symbol:STI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Canada, United States, Australia

1 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.